5VFI:
reference: Discovery of GDC-0853: A Potent, Selective, and Noncovalent Bruton's Tyrosine Kinase Inhibitor in Early Clinical Development., Crawford JJ, Johnson AR, Misner DL, Belmont LD, Castanedo G, Choy R, Coraggio M, Dong L, Eigenbrot C, Erickson R, Ghilardi N, Hau J, Katewa A, Kohli PB, Lee W, Lubach JW, McKenzie BS, Ortwine DF, Schutt L, Tay S, Wei B, Reif K, Liu L, Wong H, Young WB, J Med Chem. 2018 Feb 23. doi: 10.1021/acs.jmedchem.7b01712. PMID: 29457982

This OCA Structure page
uses Jmol, developed by the Jmol Development Team (documentation).